Jonah Voss

Nootropic formula built around Huperzine A at clinically relevant dosing, combined with Ginkgo biloba and phosphatidylserine supported by independent RCTs. The synergy between acetylcholinesterase inhibition and cerebrovascular support covers a mechanism that broad-spectrum nootropics deliberately avoid. A focused tool for a specific cognitive pathway.

Broad-spectrum nootropic covering six cognitive mechanisms simultaneously: neurotransmitter synthesis, cerebral blood flow, neuroprotection, neurogenesis, brain energy, and alpha-wave activity. Eleven ingredients with individual clinical support. The design logic is coverage across mechanisms rather than maximum dose on any single pathway.

Climate control system for sleep that manages bed temperature throughout the night via programmable profiles. Published sleep research consistently identifies thermoregulation as a primary modifiable factor in sleep architecture. The device addresses slow-wave sleep optimization through controlled cooling in a way that passive solutions cannot replicate.

Wearable device delivering low-frequency vibration patterns designed to shift autonomic nervous system balance toward parasympathetic activation. The intervention mechanism differs fundamentally from passive HRV tracking: it actively modulates the stress response rather than measuring it. Published pilot data shows measurable HRV improvements during use.

Continuous HRV and sleep tracking wearable with five independent peer-reviewed validation studies. PPG sensor accuracy for heart rate and HRV metrics shows strong agreement with clinical-grade ECG in published comparisons. The ring form factor enables 24/7 data collection including overnight autonomic assessment that wrist-based devices capture less reliably.